These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 37939908)

  • 1. The mitochondrial signature of cultured endothelial cells in sepsis: Identifying potential targets for treatment.
    Montero-Jodra A; de la Fuente MÁ; Gobelli D; Martín-Fernández M; Villar J; Tamayo E; Simarro M
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166946. PubMed ID: 37939908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis.
    Shapiro NI; Schuetz P; Yano K; Sorasaki M; Parikh SM; Jones AE; Trzeciak S; Ngo L; Aird WC
    Crit Care; 2010; 14(5):R182. PubMed ID: 20942957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MKK3 regulates mitochondrial biogenesis and mitophagy in sepsis-induced lung injury.
    Mannam P; Shinn AS; Srivastava A; Neamu RF; Walker WE; Bohanon M; Merkel J; Kang MJ; Dela Cruz CS; Ahasic AM; Pisani MA; Trentalange M; West AP; Shadel GS; Elias JA; Lee PJ
    Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(7):L604-19. PubMed ID: 24487387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.
    Hattori Y; Hattori K; Suzuki T; Matsuda N
    Pharmacol Ther; 2017 Sep; 177():56-66. PubMed ID: 28232275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 6. The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms.
    Pang J; Zheng Y; Han Q; Zhang Y; Sun R; Wang J; Xu F; Zhang Y; Ren J; Chen Y
    Adv Exp Med Biol; 2019; 1193():175-194. PubMed ID: 31368104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of endothelial cell activation in early sepsis.
    Skibsted S; Jones AE; Puskarich MA; Arnold R; Sherwin R; Trzeciak S; Schuetz P; Aird WC; Shapiro NI
    Shock; 2013 May; 39(5):427-32. PubMed ID: 23524845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energetic dysfunction in sepsis: a narrative review.
    Preau S; Vodovar D; Jung B; Lancel S; Zafrani L; Flatres A; Oualha M; Voiriot G; Jouan Y; Joffre J; Uhel F; De Prost N; Silva S; Azabou E; Radermacher P
    Ann Intensive Care; 2021 Jul; 11(1):104. PubMed ID: 34216304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial mechanisms of sepsis-induced organ failure.
    Exline MC; Crouser ED
    Front Biosci; 2008 May; 13():5030-41. PubMed ID: 18508567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Mechanisms in Septic Cardiomyopathy.
    Cimolai MC; Alvarez S; Bode C; Bugger H
    Int J Mol Sci; 2015 Aug; 16(8):17763-78. PubMed ID: 26247933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review.
    Zheng G; Lyu J; Huang J; Xiang D; Xie M; Zeng Q
    J Res Med Sci; 2015 Feb; 20(2):185-95. PubMed ID: 25983774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis.
    Lowes DA; Galley HF
    Biochem J; 2011 May; 436(1):123-32. PubMed ID: 21355852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach.
    Mokhtari B; Yavari R; Badalzadeh R; Mahmoodpoor A
    Can J Infect Dis Med Microbiol; 2022; 2022():3277274. PubMed ID: 35706715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction.
    Matsuda N; Hattori Y
    J Smooth Muscle Res; 2007 Aug; 43(4):117-37. PubMed ID: 17928746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial function in sepsis.
    Jeger V; Djafarzadeh S; Jakob SM; Takala J
    Eur J Clin Invest; 2013 May; 43(5):532-42. PubMed ID: 23496374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction and antioxidant therapy in sepsis.
    Rocha M; Herance R; Rovira S; Hernández-Mijares A; Victor VM
    Infect Disord Drug Targets; 2012 Apr; 12(2):161-78. PubMed ID: 22420514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contender.
    Fernández S; Palomo M; Molina P; Díaz-Ricart M; Escolar G; Téllez A; Seguí F; Ventosa H; Torramade-Moix S; Rovira M; Carreras E; Nicolás JM; Castro P
    J Thromb Haemost; 2021 Aug; 19(8):1948-1958. PubMed ID: 33872468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis-Induced Myocardial Dysfunction (SIMD): the Pathophysiological Mechanisms and Therapeutic Strategies Targeting Mitochondria.
    Lin Y; Xu Y; Zhang Z
    Inflammation; 2020 Aug; 43(4):1184-1200. PubMed ID: 32333359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy.
    Pan P; Wang X; Liu D
    J Int Med Res; 2018 Jun; 46(6):2157-2169. PubMed ID: 29637807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activation of endogenous protective pathways against oxidative stress under conditions of sepsis.
    McCreath G; Scullion MM; Lowes DA; Webster NR; Galley HF
    Br J Anaesth; 2016 Jan; 116(1):131-9. PubMed ID: 26675956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.